The identification of TNFR5 as a therapeutic target in diabetes

Taylor and Francis Group, Expert Opinion on Therapeutic Targets, 4(21), p. 349-351, 2017

Journal article published in 2017 by Mark D. Turner

This paper is made freely available by the publisher.

Full text: Download

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by